Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer

BACKGROUND: Circulating tumor DNA (ctDNA) is a promising biomarker for predicting relapse in multiple solid cancers. However, the predictive value of ctDNA for disease recurrence remains indefinite in locoregional gastric cancer (GC). Here, we aimed to evaluate the predictive value of ctDNA in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shu‐Qiang, Nie, Run‐Cong, Huang, You‐Sheng, Chen, Ying‐Bo, Wang, Si‐Yu, Sun, Xiao‐Wei, Li, Yuan‐Fang, Liu, Ze‐Kun, Chen, Yan‐Xing, Yao, Yi‐Chen, Xu, Yu, Qiu, Hai‐Bo, Liang, Yao, Wang, Wei, Liu, Ze‐Xian, Zhao, Qi, Xu, Rui‐Hua, Zhou, Zhi‐Wei, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693304/
https://www.ncbi.nlm.nih.gov/pubmed/37837629
http://dx.doi.org/10.1002/cac2.12494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693304/
https://www.ncbi.nlm.nih.gov/pubmed/37837629
http://dx.doi.org/10.1002/cac2.12494

Ejemplares similares